Literature DB >> 7351502

Increased granulocyte adherence in psoriasis and psoriatic arthritis.

J B Sedgwick, P R Bergstresser, E R Hurd.   

Abstract

Circulating polymorphonuclear leukocytes (PMN) from patients with psoriasis and psoriatic arthritis were found to be significantly more adherent to nylon fiber columns when compared with both normal and nonpsoriatic patient control groups. The increased adherence correlated positively with the extent of disease and was highest in those patients with psoriatic arthritis. Total leukocyte and PMN counts were increased in psoriasis patients and were highest in the psoriatic arthritis group. No increase in cell counts was found for mononuclear leukocytes. PMN adherence was not increased in lithium-treated patients or a nonpsoriatic patient control group although such patients did have significant granulocytosis. PMN's are frequently present in lesions of psoriasis as are activated complement components and abnormal keratinocyte cyclic nucleotide levels. These factors or others may cause a generalized activation of PMN's in psoriasis leading to migration of neutrophils into the skin lesion. The present study demonstrates a systemic effector cell alteration in psoriasis and contradicts the general concept that uncomplicated psoriasis is limited to the skin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7351502     DOI: 10.1111/1523-1747.ep12519947

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  15 in total

1.  Myeloperoxidase of polymorphonuclear leukocytes in psoriasis vulgaris.

Authors:  H Greiten; M Rister; G K Steigleder
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

2.  Leukopheresis for treatment of psoriasis: is therapeutical benefit related to reduced activities of neutral proteinases of polymorphonuclear leukocytes?

Authors:  W Gliński; D Barszcz; S Jabłońska; Z Zarebska; M Tigałonowa; E Janczura
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

3.  Alpha 1-proteinase inhibitor in psoriasis: reduced activity in symptom-free patients and during flare.

Authors:  D Barszcz; Z Zarebska; M Glińska-Ferenz; S Jabłońska; M Tigałonowa; W Gliński
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

4.  Decreased extracellular release of granule enzymes from in vitro-stimulated polymorphonuclear leukocytes in guttate psoriasis.

Authors:  W Glinski; M Tigalonowa; S Jablonska; E Janczura
Journal:  Inflammation       Date:  1986-06       Impact factor: 4.092

5.  Enhanced chemiluminescence production by phagocytosing neutrophils in psoriasis.

Authors:  F J Bloomfield; M M Young
Journal:  Inflammation       Date:  1988-04       Impact factor: 4.092

6.  Is chemotactic activity of polymorphonuclear leukocytes increased in psoriasis?

Authors:  A Langner; T P Chorzelski; M Fraczykowska; S Jabłońska
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

7.  Increased in vivo secretory activity of neutrophil granulocytes in patients with psoriasis and palmoplantar pustulosis.

Authors:  A Lundin; L Håkansson; R Hällgren; G Michaëlsson; P Venge
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

8.  Activity of some lysosomal enzyme in rheumatoid and psoriatic arthritis.

Authors:  D Mikulíková; M Stancíková; K Trnavský; F Vlcek
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

9.  Lithium and psoriasis: what primary care and family physicians should know.

Authors:  Mohammad Jafferany
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

10.  Defective natural-killer- and killer-cell activity associated with increased polymorphonuclear leukocyte adherence in psoriasis.

Authors:  S Majewski; M Wasik; S Jabłońska; M Kamiński; M Fraczykowska
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.